COVID-19 e diabetes mellitus: O impacto entre duas pandemias mundiais / COVID-19 and diabetes mellitus: The impact between two global pandemics

Authors

  • Vitória Sampaio Cunha
  • Wilmar Barros Muniz Carrera
  • Mariana de Oliveira Dantas Silva

DOI:

https://doi.org/10.34119/bjhrv5n1-290

Keywords:

Coronavírus, COVID-19, SARS-COV-2, Diabetes Mellitus, Pandemia.

Abstract

A pandemia global causada pelo novo coronavírus, o SARS-COV-2, que emergiu no final do ano de 2019 é responsável por grande impacto mundial devido a sua gravidade. Destaca-se neste cenário a diabetes mellitus, uma das comorbidades mais prevalentes entre os pacientes infectados, os quais tem demonstrado pior desfecho e maior morbimortalidade em comparação com indivíduos sem comorbidades que apresentam essa doença. O objetivo deste artigo é explorar a relação bidirecional entre essas duas pandemias: a nova doença da COVID-19 que se dissemina por diversos países e a diabetes mellitus que já apresentava avanço no cenário global. Serão abordados aspectos relacionados a fisiopatologia, como a disfunção imune do diabético, aumento da expressão nesses indivíduos da enzima conversora da angiotensina 2, a qual é utilizada pelo SARS-CoV-2 durante a invasão celular e a alteração direta da função pancreática causada pela infecção viral. Além disso, serão apresentados aspectos relacionados ao manejo da hiperglicemia presente no diabetes durante a pandemia da COVID-19.

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-9.

Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ 2020;368:m1036. https://doi.org/10.1136/ bmj.m1036.

WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organisation; 2021.

International Diabetes Federation. IDF Diabetes Atlas,9th: edn. Belgium: Brussels, 2019. https://www.diabetesatlas.org/ en/. Acesso em 13 de Dezembro de 2021

The novel coronavirus pneumonia emergency response epidemiology team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China, 2020. China CDC Weekly. 2020;2:113-22. Available from http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4- 41e9-9a9b-fea8db1a8f51

Gentile S, Strollo F, Ceriello A. COVID-19 infection in Italian people with diabetes: lessons learned for our future (an experience to be used). Diabetes Res Clin Pract 2020 Apr;162:108137. https://doi.org/10.1016/ j.diabres.2020.108137. Epub 2020 Apr 4

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020; 22:e206775. doi: 10.1001/jama.2020.6775.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan. China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20.

Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):535-545. doi: 10.1016/j.dsx.2020.04.044. Epub 2020 May 6. PMID: 32408118; PMCID: PMC7200339.

Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020; https://doi.org/10.1164/rccm.202003- 0543oc.

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020a. https:// doi.org/10.1183/13993003.00547- 2020

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; https://doi.org/10.1007/ s00392- 020- 01626- 9.

Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239-1242.

Fadini GP, Morieri ML, Longato E, et al. Prevalence and impact of diabetes among people infected with SARS-CoV- 2. J Endocrinol Invest 2020; 43: 867–869.

Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 dia- betes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442-449.

Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513-521.

Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol 2001; 38: 77–82.

Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197–216.

Muniyappa R, Gubbi S. COVID-19 pandemic, corona viruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020; 318: E736–E741.

Rao S, Lau A, So H-C. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian randomization analysis (Preprint) medRxiv: 2020.2003.2004.20031237, 2020. doi:10.1101/2020.03.04.20031237.

Rego F, Picheth G et al. A epidemia do Diabetes mellitus encontra a pandemia da SARS- CoV-2 (COVID-19). Brazilian Journal of Health Review. Curitiba, v.4, n.3, p. 10886-10920 may/jun, 2021.

Palm NW, Medzhitov R. Not so fast: adaptive suppression of innate immunity. Nat Med 13: 1142–1144, 2007. doi:10.1038/nm1007-1142

Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 2020; 29: 108132.

Rodríguez-Hernandez H, Simental-Mendía LE, Rodríguez-Ramírez G, et al. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013; 2013: 678159.

Chee YJ, Tan SK, Yeoh E. Dissecting the interaction between COVID-19 and diabetes mellitus. J Diabetes Investig. 2020 Sep;11(5):1104-1114. doi: 10.1111/jdi.13326. Epub 2020 Aug 5. PMID: 32558211; PMCID: PMC7323255.

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020:e3319.

Philips BJ, Meguer JX, Redman J, et al. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med 2003; 29: 2204–2210.

Chen X, Wenjia H, Ling J, et al. Hypertension and diabetes delay the viral clearance in COVID-19 patients. medRxiv 2020. https://doi.org/10.1101/2020.03.22.20040774

Aquino PA, Silva AF et al. Influência do DM2 e do controle glicêmico no prognóstico de pacientes infectados por COVID-19. Brazilian Journal of Health Review. Curitiba, v.3, n.4, p. 11120 – 11130, jul/ago, 2020.

Yang JK, Lin SS, Ji XJ, et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010; 47: 193–199.

Dungan KM, Braithwaite SS, Preiser J-C. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–1807

Mader JK, Brix J, Aberer F, Vonbank A, Resl M, Pieber TR, et al. Hospital diabetes management (Update 2019) Wien Klin

James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, et al. A meta-analysis of the association of estimated GFR, Albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis. 2015;66(4):602–612.

Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;2(2):95–108.

Published

2022-02-18

How to Cite

CUNHA, V. S.; CARRERA, W. B. M.; SILVA, M. de O. D. COVID-19 e diabetes mellitus: O impacto entre duas pandemias mundiais / COVID-19 and diabetes mellitus: The impact between two global pandemics. Brazilian Journal of Health Review, [S. l.], v. 5, n. 1, p. 3307–3314, 2022. DOI: 10.34119/bjhrv5n1-290. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44289. Acesso em: 29 mar. 2024.

Issue

Section

Original Papers